The growing trend of using medications originally intended for diabetes treatment for rapid weight loss is raising concerns among medical professionals in Austria. Dr. Eva Wegrostek, a Vienna-based physician considered a pioneer in the field of medical aesthetics, has cautioned against the hype surrounding these drugs, warning of potential health risks and the importance of responsible medical practice. The increasing demand for these medications, often referred to as “weight loss injections,” is prompting a broader discussion about body image, societal pressures, and the ethical considerations within aesthetic medicine.
While the specific medications Dr. Wegrostek refers to weren’t explicitly named in initial reports, the discussion centers around drugs like semaglutide and liraglutide, which are GLP-1 receptor agonists initially developed to manage type 2 diabetes. These medications function by mimicking a natural hormone that regulates appetite and blood sugar levels, leading to weight loss as a side effect. However, their use for cosmetic weight loss, outside of a medically supervised context for diabetes management, is what’s drawing scrutiny. The popularity of these drugs has surged, fueled in part by social media trends and celebrity endorsements, leading to shortages and concerns about access for patients who genuinely need them for diabetes treatment.
A Shift Towards Natural Refreshment in Aesthetic Medicine
Dr. Wegrostek’s concerns come amidst a broader shift in the Austrian aesthetic medicine landscape. According to a report from December 2025, the field has moved from a niche market to a mainstream practice, with an estimated 40,000 to 50,000 aesthetic surgeries and over 70,000 non-surgical treatments performed annually. Despite the lack of official national statistics, experts note a growing preference for subtle refreshment and natural-looking results, rather than dramatic transformations.
This trend is reflected in the practices of Dr. Wegrostek and her daughter, Dr. Isabelle Sawetz-Paiva, a plastic and aesthetic surgeon. Since March 2025, the two have collaborated, combining Dr. Wegrostek’s two decades of experience in gentle medical aesthetics with Dr. Sawetz-Paiva’s expertise in modern aesthetic surgery and longevity medicine. They emphasize enhancing individual beauty without altering core features, a philosophy that stands in contrast to the pursuit of extreme transformations often seen on social media. As Dr. Sawetz-Paiva noted in an interview with KURIER TV Weekend, the market for collagen-based products is booming, but the efficacy and credibility of related studies are often questionable.
The Risks of Off-Label Medication Use
The use of diabetes medications for weight loss carries potential risks, even under medical supervision. Common side effects can include nausea, vomiting, diarrhea, and constipation. More serious, though less common, risks include pancreatitis, gallbladder problems, and potential thyroid tumors. The long-term effects of using these medications for extended periods solely for weight loss are still largely unknown. Dr. Wegrostek’s warning underscores the importance of a thorough medical evaluation and a discussion of potential risks and benefits before considering any weight loss intervention.
The concern extends beyond individual health risks. The increased demand for these drugs is creating shortages, potentially impacting access for individuals with diabetes who rely on them for life-sustaining treatment. This raises ethical questions about prioritizing cosmetic desires over medical necessity. The unregulated nature of some weight loss clinics and the availability of these medications through unofficial channels pose additional risks, as patients may not receive proper medical supervision or be aware of potential counterfeit products.
Longevity Medicine and the Future of Aesthetic Treatments
The growing interest in longevity medicine is also influencing the field of aesthetic treatments in Austria. Dr. Wegrostek and Dr. Sawetz-Paiva are integrating longevity principles into their practice, focusing on treatments that promote overall health and well-being, rather than solely addressing cosmetic concerns. This approach emphasizes preventative care, lifestyle modifications, and treatments that support the body’s natural aging process.
Recent beauty trends, such as the use of salmon sperm in facial treatments – popularized by celebrities like Jennifer Aniston and Kim Kardashian – are also being scrutinized by experts. Dr. Wegrostek and Dr. Sawetz-Paiva discussed the credibility of studies supporting such treatments in an interview with KURIER TV, highlighting the need for evidence-based practices in the aesthetic medicine field. Dr. Wegrostek’s practice in Vienna offers a range of treatments, including CO2 laser resurfacing (ranging from €490 to €2,990 depending on intensity) and chemical peels (starting at €380), with a focus on providing safe and effective options for patients seeking to enhance their natural beauty. Her clinic is open daily from 9:00 AM to 7:00 PM, and Dr. Sawetz-Paiva also holds appointments on Mondays, Thursdays, and Fridays.
The next scheduled appearance of Dr. Isabelle Sawetz-Paiva is not currently publicized, but her work continues alongside Dr. Wegrostek. As the demand for aesthetic treatments continues to grow, the need for responsible medical practice, informed patient choices, and a focus on long-term health and well-being will become increasingly crucial.
This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It’s essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Have your own thoughts on the rise of weight loss injections and the evolving landscape of aesthetic medicine? Share your comments below and help us continue the conversation.
